Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

School of Public Health: Bar-Tana Jacob

Researchers / חוקרים

 Last updated June 2021 - School of Public Health

List of Publications

(1) Aisen Y, Gatt ME, Hertz R, Smeir E, Bar-Tana J. Suppression of multiple myeloma by mitochondrial targeting. Sci Rep 2021;11(1).

(2) Bar-Tana J. Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Rev Endocr Metab Disord 2020;21(4):613-629.

(3) Valitsky M, Hoffman A, Unterman T, Bar-Tana J. Insulin sensitizer prevents and ameliorates experimental type 1 diabetes. Am J Physiol Endocrinol Metab 2017;313(6):E672-E680.

(4) Atiq R, Hertz R, Eldad S, Smeir E, Bar-Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget 2016;7(14):18694-18704.

(5) Gluschnaider U, Hertz R, Ohayon S, Smeir E, Smets M, Pikarsky E, et al. Long-chain fatty acid analogues suppress breast tumorigenesis and progression. Cancer Res 2014;74(23):6991-7002.

(6) Vainer GW, Saada A, Kania-Almog J, Amartely A, Bar-Tana J, Hertz R. PF-4708671 activates AMPK independently of p70S6K1 inhibition. PLoS ONE 2014;9(9).

(7) Yehuda-Shnaidman E, Kalderon B, Bar-Tana J. Thyroid hormone, thyromimetics, and metabolic efficiency. Endocr Rev 2014;35(1):35-58.

(8) Algamas-Dimantov A, Yehuda-Shnaidman E, Hertz R, Peri I, Bar-Tana J, Schwartz B. Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic. Oncotarget 2014;5(20):9851-9863.

(9) Algamas-Dimantov A, Davidovsky D, Ben-Ari J, Kang JX, Peri I, Hertz R, et al. Amelioration of diabesity-induced colorectal ontogenesis by omega-3 fatty acids in mice. J Lipid Res 2012;53(6):1056-1070.

(10) Kalderon B, Azazmeh N, Azulay N, Vissler N, Valitsky M, Bar-Tana J. Suppression of adipose lipolysis by long-chain fatty acid analogs. J Lipid Res 2012;53(5):868-878.

(11) Zatara G, Hertz R, Shaked M, Mayorek N, Morad E, Grad E, et al. Suppression of FoxO1 activity by long-chain fatty acyl analogs. Diabetes 2011;60(7):1872-1881.

(12) Samovski D, Kalderon B, Yehuda-Shnaidman E, Bar-Tana J. Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs in vivo. J Biol Chem 2010;285(10):6879-6890.

(13) Yehuda-Shnaidman E, Kalderon B, Azazmeh N, Bar-Tana J. Gating of the mitochondrial permeability transition pore by thyroid hormone. FASEB J 2010;24(1):93-104.

(14) Schwartz B, Algamas-Dimantav A, Hertz R, Natal J, Kerman A, Peri I, et al. Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4α. Int J Cancer 2009;124(5):1081-1089.

(15) Za'tara G, Bar-Tana J, Kalderon B, Suter M, Morad E, Samovski D, et al. AMPK activation by long chain fatty acyl analogs. Biochem Pharmacol 2008;76(10):1263-1275.

(16) Shabalina IG, Backlund EC, Bar-Tana J, Cannon B, Nedergaard J. Within brown-fat cells, UCP1-mediated fatty acid-induced uncoupling is independent of fatty acid metabolism. Biochim Biophys Acta Bioenerg 2008;1777(7-8):642-650.

(17) Las G, Mayorek N, Dickstein K, Bar-Tana J. Modulation of insulin secretion by fatty acyl analogs. Diabetes 2006;55(12):3478-3485.

(18) Sheena V, Hertz R, Berman I, Nousbeck J, Bar-Tana J. Transcriptional suppression of human microsomal triglyceride transfer protein by hypolipidemic insulin sensitizers. Biochem Pharmacol 2005;70(11):1548-1559.

(19) Hertz R, Kalderon B, Byk T, Berman I, Za'Tara G, Mayer R, et al. Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor-4α. J Biol Chem 2005;280(26):24451-24461.

(20) Schroeder F, Huang H, Hostetler HA, Petrescu AD, Hertz R, Bar-Tana J, et al. Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4α and peroxisome proliferator-activated receptor-α. Lipids 2005;40(6):559-568.

(21) Magenheim J, Hertz R, Berman I, Nousbeck J, Bar-Tana J. Negative autoregulation of HNF-4α gene expression by HNF-4α1. Biochem J 2005;388(1):325-332.

(22) Yehuda-Shnaidman E, Kalderon B, Bar-Tana J. Modulation of mitochondrial transition pore components by thyroid hormone. Endocrinology 2005;146(5):2462-2472.

(23) Petrescu AD, Hertz R, Bar-Tana J, Schroeder F, Kier AB. Role of regulatory F-domain in hepatocyte nuclear factor-4α ligand specificity. J Biol Chem 2005;280(17):16714-16727.

(24) Sheena V, Hertz R, Nousbeck J, Berman I, Magenheim J, Bar-Tana J. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4α. J Lipid Res 2005;46(2):328-341.

(25) Bronner M, Hertz R, Bar-Tana J. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor α by AMP-activated protein kinase. Biochem J 2004;384(2):295-305.

(26) Bar-Tana J. Hypolipidemia induced by PPARα agonists: HNF-4α as an alternative to PPARα. Curr Opin Invest Drugs 2004;5(9):941-946.

(27) Petrescu AD, Payne HR, Boedecker A, Chao H, Hertz R, Bar-Tana J, et al. Physical and Functional Interaction of Acyl-CoA-binding Protein with Hepatocyte Nuclear Factor-4α. J Biol Chem 2003;278(51):51813-51824.

(28) Hertz R, Ben-Haim N, Petrescu AD, Kalderon B, Berman I, Eldad N, et al. Rescue of MODY-1 by agonist ligands of hepatocyte nuclear factor-4α. J Biol Chem 2003;278(25):22578-22585.

(29) Kalderon B, Mayorek N, Ben-Yaacov L, Bar-Tana J. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo. Am J Physiol Endocrinol Metab 2003;284(4 47-4):E795-E803.

(30) Kalderon B, Sheena V, Shachrur S, Hertz R, Bar-Tana J. Modulation by nutrients and drugs of liver acyl-CoAs analyzed by mass spectrometry. J Lipid Res 2002;43(7):1125-1132.

(31) Bartoov-Shifman R, Hertz R, Wang H, Wollheim CB, Bar-Tana J, Walker MD. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4α. J Biol Chem 2002;277(29):25914-25919.

(32) Petrescu AD, Hertz R, Bar-Tana J, Schroeder F, Kier AB. Ligand specificity and conformational dependence of the hepatic nuclear factor-4α (HNF-4α). J Biol Chem 2002;277(27):23988-23999.

(33) Atkinson LL, Kelly SE, Russell JC, Bar-Tana J, Lopaschuk GD. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR:LA-cp rats. Diabetes 2002;51(5):1548-1555.

(34) Hertz R, Sheena V, Kalderon B, Berman I, Bar-Tana J. Suppression of hepatocyte nuclear factor-4α by acyl-CoA thioesters of hypolipidemic peroxisome proliferators. Biochem Pharmacol 2001;61(9):1057-1062.

(35) Bar-Tana J. Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans. Toxicol Lett 2001;120(1-3):9-19.

(36) Hermesh O, Kalderon B, Berman B, Bar-Tana J. Mitochondrial protonophoric activity induced by a thyromimetic fatty acid analogue. Biochim Biophys Acta Bioenerg 2000;1457(3):166-174.

(37) Kalderon B, Mayorek N, Berry E, Zevit N, Bar-Tana J. Fatty acid cycling in the fasting rat. Am J Physiol Endocrinol Metab 2000;279(1 42-1):E221-E227.

(38) Popa R, Salem L, Schwalb H, Merin G, Borman JB, Bar-Tana J. Protection by cyclosporin A from cardiac ischemia-reperfusion damage. Exp Clin Cardiol 2000;5(2):77-81.

(39) Hertz R, Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol Lett 1998;102-103:85-90.

(40) Bar-Tana J. Transcriptional modulation of hepatocyte nuclear factor 4a (HNF-4a) and/or peroxisome proliferator-activated receptor a (PPARa)-controlled genes by low molecular weight compounds. Expert Opin Ther Targets 1998;2(1):141-144.

(41) Russell JC, Shillabeer G, Bar-Tana J, Lau DCW, Richardson M, Wenzel LM, et al. Development of insulin resistance in the JCR:LA-cp rat: Role of triacylglycerols and effects of MEDICA 16. Diabetes 1998;47(5):770-778.

(42) Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 1998;392(6675):512-516.

(43) Hermesh O, Kalderon B, Bar-Tana J. Mitochondria uncoupling by a long chain fatty acyl analogue. J Biol Chem 1998;273(7):3937-3742.

(44) Mayorek N, Kalderon B, Itach E, Bar-Tana J. Sensitization to insulin induced by β,β'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Diabetes 1997;46(12):1958-1964.

(45) Hertz R, Seckbach M, Zakin MM, Bar-Tana J. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J Biol Chem 1996;271(1):218-224.

(46) Hertz R, Bishara-Shieban J, Bar-Tana J. Hypolipidemic Effect of Peroxisome Proliferators: Transcriptional Suppression of Apolipoprotein C-III. Ann New York Acad Sci 1996;804:731-733.

(47) Hertz R, Berman I, Keppler D, Bar-Tana J. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR). Eur J Biochem 1996;235(1-2):242-247.

(48) Hertz R, Nikodem V, Ben-Ishai A, Berman I, Bar-Tana J. Thyromimetic mode of action of peroxisome proliferators: Activation of 'malic' enzyme gene transcription. Biochem J 1996;319(1):241-248.

(49) Brandes R, Arad R, Bar-Tana J. Inducers of adipose conversion activate transcription promoted by a peroxisome proliferators response element in 3T3-L1 cells. Biochem Pharmacol 1995;50(11):1949-1951.

(50) Kalderon B, Hermesh O, Bar-Tana J. Mitochondrial permeability transition is induced by in vivo thyroid hormone treatment. Endocrinology 1995;136(8):3552-3556.

(51) Hertz R, Bishara-Shieban J, Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J Biol Chem 1995;270(22):13470-13475.

(52) Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β'-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 1995;15(7):918-923.

(53) Jedlitschky G, Leier I, Böhme M, Buchholz U, Bar-Tana J, Keppler D. Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent atp-dependent transport across the canalicular membrane. Biochem Pharmacol 1994;48(6):1113-1120.

(54) HERTZ R, BERMAN I, BAR‐TANA J. Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl‐CoA derivative. Eur J Biochem 1994;221(1):611-615.

(55) Frenkel B, Bishara-Shieban J, Bar-Tana J. The effect of β,β'-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: Role of apolipoprotein C-III. Biochem J 1994;298(2):409-414.

(56) Brandes R, Arad R, Gaathon A, Bar-Tana J. Induction of adipose conversion in 3T3-L1 cells is associated with an early phosphorylation of a protein partly homologous with mouse vimentin. FEBS Lett 1993;333(1-2):179-182.

(57) Mayorek N, Bar-Tana J. Hypocholesterolaemic effect of ββ-methyl-substituted hexadecanedioic acid (MEDICA 16) in the male hamster. Biochem J 1993;289(3):911-917.

(58) Hertz R, Kalderon B, Bar-Tana J. Thyromimetic effect of peroxisome proliferators. Biochimie 1993;75(3-4):257-261.

(59) Hertz R, Bar-Tana J. Induction of peroxisomal β-oxidation genes by retinoic acid in cultured rat hepatocytes. Biochem J 1992;281(1):41-43.

(60) Kalderon B, Hertz R, Bar-Tana J. Effect of thyroid hormone treatment on redox and phosphate potentials in rat liver. Endocrinology 1992;131(1):400-407.

(61) Kalderon B, Hertz R, Bar-Tana J. Tissue selective modulation of redox and phosphate potentials by β,β′-methyl-substituted hexadecanedioic acid. Endocrinology 1992;131(4):1629-1635.

(62) Kalderon B, Hertz R, Bar-Tana J. Erratum: Effect of thyroid hormone treatment on redox and phosphate potentials in rat liver (Endocrinology (1992) 131 (400-407)). Endocrinology 1992;131(4):1962.

(63) Brandes R, Arad R, Bar-Tana J. The induction of adipose conversion in 3T3-L1 cells is associated with early phosphorylation of a 60-kDa nuclear protein. FEBS Lett 1991;285(1):63-65.

(64) Hertz R, Aurbach R, Hashimoto T, Bar-Tana J. Thyromimetic effect of peroxisomal proliferators in rat liver. Biochem J 1991;274(3):745-751.

(65) Russell JC, Dolphin PJ, Hameed M, Stewart B, Koeslag DG, Rose-Kahn G, et al. Hypolipidemic effect of β,β'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Arterioscler Thromb 1991;11(3):602-609.

(66) Almagor M, Bar-Tana J. Retinoic acid inhibits the myristoylation of a membrane protein in HL-60 cells. Biochem Biophys Res Commun 1990;172(2):877-882.

(67) Brandes R, Arad R, Benvenisty N, Weil S, Bar-Tana J. The induction of adipose conversion by bezafibrate in 3T3-L1 cells. Synergism with dibutyryl-cAMP. Biochim Biophys Acta Mol Cell Res 1990;1054(2):219-224.

(68) Rose-Kahn G, Bar-Tana J. Inhibition of rat liver acetyl-CoA carboxylase by β,β′-tetramethyl-substituted hexadecanedioic acid (MEDICA 16). Biochim Biophys Acta Lipids Lipid Metab 1990;1042(2):259-264.

(69) Bar-tana J, Ben-shoshan S, Blum J, Migron Y, Hertz R, Bar-tana-rose-khan G, et al. Synthesis and Hypolipidemic and Antidiabetogenic Activities of β,β,β',β'-tetrasubstituted, Long-chain Dioic Acids. J Med Chem 1989;32(9):2072-2084.

(70) Rosen G, Bar-Tana J. Fatty acyl coupled catalase. Biochim Biophys Acta Protein Struct Mol Enzymol 1989;994(3):264-269.

(71) Mayorek N, Bar-Tana J. Lipid synthesis in permeabilized cultured rat hepatocytes. J Biol Chem 1989;264(8):4450-4455.

(72) MAYOREK N, GRINSTEIN I, BAR‐TANA J. Triacylglycerol synthesis in cultured rat hepatocytes: The rate‐limiting role of diacylglycerol acyltransferase. Eur J Biochem 1989;182(2):395-400.

(73) Tzur R, Smith E, Bar-Tana J. Adipose reduction by β,β'-tetramethyl-substituted hexadecanedioic acid( MEDICA 16). Int J Obes 1989;13(3):313-326.

(74) Hertz R, Bar-Tana J, Sujatta M, Pill J, Schmidt FH, Fahimi HD. The induction of liver peroxisomal proliferation by β,β′-methyl-substituted hexadecanedioic acid (MEDICA 16). Biochem Pharmacol 1988;37(19):3571-3577.

(75) Hertz R, Bar-Tana J. The acylation of proteins by xenobiotic amphipatic carboxylic acids in cultured rat hepatocytes. Biochem J 1988;254(1):39-44.

(76) Tzur R, Rose-Kahn G, Adler JH, Bar-Tana J. Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of β,β'-methyl-substituted hexadecanedioic acid in sand rats. Diabetes 1988;37(12):1618-1624.

(77) Frenkel B, Mayorek N, Hertz R, Bar-Tana J. The hypochylomicronemic effect of β,β'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III. J Biol Chem 1988;263(17):8491-8497.

(78) Bar-Tana J, Rose-Kahn G, Frenkel B, Shafer Z, Fainaru M. Hypolipidemic effect of β,β'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J Lipid Res 1988;29(4):431-441.

(79) Brandes R, Hertz R, Arad R, Naishtat S, Weil S, Bar-Tana J. Adipocyte conversion of cultured 3T3-Ll preadipocytes by bezafibrate. Life Sci 1987;40(10):935-941.

(80) Hertz R, Bar-Tana J. Increased response to peroxisomal proliferators in starved rats. Biochim Biophys Acta Lipids Lipid Metab 1987;917(1):57-61.

(81) Hertz R, Bar-Tana J. Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo. Biochem J 1987;245(2):387-392.

(82) Migron Y, Blum J, Bar-Tana J. A facile synthesis of α,α,ω,ω-tetrahalo-α,ω-dicarboxylic esters. Tetrahedron 1987;43(2):361-364.

(83) Hertz R, Arnon J, Hoter A, Shouval D, Bar-Tana J. Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-HEP-1. Cancer Lett 1987;34(3):263-272.

(84) Brandes R, Arad R, Bar-Tana J. Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs. Biochim Biophys Acta Lipids Lipid Metab 1986;877(2):314-321.

(85) Hertz R, Bar-Tana J. Reductive repression in Escherichia coli K-12 is mediated by oxygen radicals. Arch Biochem Biophys 1986;250(1):54-62.

(86) Bar-Tana J, Rose-Kahn G, Srebnik M. Inhibition of lipid synthesis by ββ'-tetramethyl-substituted, C14-C22, α,ω-dicarboxylic acids in the rat in vivo. J Biol Chem 1985;260(14):8404-8410.

(87) Hertz R, Arnon J, Bar-Tana J. The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes. Biochim Biophys Acta Lipids Lipid Metab 1985;836(2):192-200.

(88) Brandes R, Mayorek N, Berry E, Arad R, Bar-Tana J. The specificity of triacylglycerol synthesis for medium-chain fatty acids in rat and human adipose preparations. Biochim Biophys Acta Lipids Lipid Metab 1985;836(1):63-66.

(89) Mayorek N, Bar-Tana J. Inhibition of diacylglycerol acyltransferase by 2-bromooctanoate in cultured rat hepatocytes. J Biol Chem 1985;260(11):6528-6532.

(90) Rose-Kahn G, Bar-Tana J. Inhibition of lipid synthesis by ββ'-tetramethyl-substituted, C14-C22, α,ω-dicarboxylic acids in cultured rat hepatocytes. J Biol Chem 1985;260(14):8411-8415.

(91) Rosen G, Bar-Tana J. Sepharose-stearate as substrate for rat liver long-chain fatty acyl-CoA synthetase. Biochim Biophys Acta Protein Struct Mol Enzymol 1983;743(1):121-128.

(92) Mayorek N, Bar Tana J. Medium chain fatty acids as specific substrates for diglyceride acyltransferase in cultured hepatocytes. J Biol Chem 1983;258(11):6789-6792.

(93) Hertz R, Bar-Tana J. Modulation of the 3′,5′-cyclic AMP content by the respiration rate in E. coli K-12. Arch Biochem Biophys 1982;213(1):193-199.

(94) Brandes R, Arad R, Bar-Tana J. Translocation of long chain fatty acids into lecithin liposomes containing the long chain fatty acyl-CoA synthetase. FEBS Lett 1981;123(2):295-299.

(95) Almagor M, Ron A, Bar‐Tana J. Chemotaxis in Tetrahymena thermophila. Cell Motil 1981;1(2):261-268.

(96) Howlett BJ, Bar-Tana J. Polyprenyl p-hydroxybenzoate carboxylase in flagellation of Salmonella typhimurium. J Bacteriol 1980;143(2):644-651.

(97) Bar-Tana J, Howlett BJ, Hertz R. Ubiquinone synthetic pathway in flagellation of Salmonella typhimurium. J Bacteriol 1980;143(2):637-643.

(98) Rose G, Bar-Tana J, Shapiro B. Palmitoyl coenzyme a synthetase activation by uncomplexed ATP. Biochim Biophys Acta Lipids Lipid Metab 1979;573(1):126-135.

(99) Hertz R, Bar-Tana J. Anaerobic electron transport in anaerobic flagellum formation in Escherichia coli. J Bacteriol 1977;132(3):1034-1035.

(100) Maes E, Bar-Tana J. Rat liver microsomal palmitoyl-CoA synthetase: Subunit structure. BBA - Enzymology 1977;480(2):527-530.

(101) Almagor M, Bar-Tana J, Ron A. Chemotaxis in Tetrahymena. J Cell Biol 1977;75(2 II).

(102) Bar-Tana J, Rose G, Shapiro B. [15] Long-chain fatty acyl-CoA synthetase from rat liver microsomes. Methods Enzymol 1975;35(C):117-122.

(103) Rose IA, O'Connell EL, Litwin S, Bar Tana J. Determination of the rate of hexokinase glucose dissociation by the isotope trapping method. J Biol Chem 1974;249(16):5163-5168.

(104) Bar Tana J, Cleland WW. Rabbit muscle phosphofructokinase. II. Product and dead end inhibition. J Biol Chem 1974;249(4):1271-1276.

(105) Bar Tana J, Cleland WW. Rabbit muscle phosphofructokinase. I. Anomeric specificity; initial velocity kinetics. J Biol Chem 1974;249(4):1263-1270.

(106) Bar-Tana J, Rose G. Rat liver microsomal palmitoyl-coenzyme A synthetase. Structural properties. Biochem J 1973;131(3):443-449.

(107) Bar Tana J, Rose G, Shapiro B. Palmitoyl coenzyme A synthetase. Isolation of an enzyme bound intermediate. Biochem J 1973;135(3):411-416.

(108) Bar-Tana J, Rose G, Brandes R, Shapiro B. Palmitoyl-coenzyme A synthetase. Mechanism of reaction. Biochem J 1973;131(2):199-209.

(109) Bar-Tana J, Ben-Zeev O, Rose G, Deutshi J. Determination of 18O content of phosphate compounds - a novel method. Biochim Biophys Acta Gen Subj 1972;264(1):214-219.

(110) Bar-Tana J, Rose G, Shapiro B. Microsomal palmitoyl coenzyme A synthetase from rat liver. Partial and exchange reactions. Biochem J 1972;129(5):1101-1107.

(111) Bar-Tana J, Rose G, Shapiro B. The purification and properties of microsomal palmitoyl-coenzyme A synthetase. Biochem J 1971;122(3):353-362.

(112) Bar-Tana J, Rose G. Studies on medium-chain fatty acyl-coenzyme a synthetase. Enzyme fraction II: mechanism of reaction and specific properties. Biochem J 1968;109(2):283-292.

(113) Bar-Tana J, Rose G. Studies on medium-chain fatty acyl-coenzyme a synthetase. Enzyme fraction I: mechanism of reaction and allosteric properties. Biochem J 1968;109(2):275-282.

(114) Bar-Tana J, Rose G, Shapiro B. Studies on medium-chain fatty acyl-coenzyme a synthetase. Purification and properties. Biochem J 1968;109(2):269-274.

(115) Bar-Tana J, Shapiro B. Studies on palmitoyl-coenzyme A synthetase. Biochem J 1964;93(3):533-538.